Analysis of pathophysiological functions of RAGE using genetically engineered models and adenovirus expression
Information updated: July 31, 2023
- Seeds Information
- Researcher Information
- What do you expect from collaboration with companies?
- Contact for this research
Seeds Information
keyword
Chronic subclinical inflammation, cognitive function, RAGE
Field
Research into the onset and prevention of cognitive impairment in lifestyle-related diseases and diabetes
Overview
Using endothelial cells as a setting, we clarified the relationship and mechanism of the inflammatory signal caused by the receptor for advanced glycation end products (RAGE) and its cleavage (Miyoshi A et al. FASEB J 33: 3575-3589, 2019; Figure 1). In recent years, cognitive impairment due to obesity and diabetes has attracted attention. In light of the reports of the involvement of immune cells, brain inflammation, and cerebrovascular inflammation in the pathology of cognitive impairment, this research project adopts a chronic latent inflammation model and a high-fat diet-induced obesity model, and uses the following various genetically modified mice and chimeric mice to aim to obtain knowledge about the involvement of RAGE in peripheral immune cells, brain and cerebrovascular inflammation, latent inflammation, and the significance of cognitive impairment, as well as their control.
- Vascular endothelium-specific human RAGE overexpression mice → Physiology significance of RAGE in vascular endothelium can be investigated
- RAGE-deficient mice: the whole-body effects of RAGE deficiency can be examined
- Chimeric mice: bone marrow from RAGE-deficient mice was transplanted into CD45.1 mice, enabling the effects of RAGE deficiency on immune cells to be examined.
- Microglia and vascular endothelium-specific RAGE-deficient mice → Physiology significance of RAGE in microglia and vascular endothelium can be examined
What's new?
Clarification of the relationship and mechanism of inflammatory signaling caused by the cleavage of the receptor for advanced glycation end products (RAGE) in vascular endothelial cells
What are its advantages over other studies?
We have conducted clinical and basic research focusing on RAGE and have acquired the necessary know-how and tools.
- Adenovirus-mediated overexpression of human RAGE and esRAGE (in vitro, in vivo)
- RAGE-deficient mice are useful for verifying the in vivo action of RAGE, chimeric mice using bone marrow transplantation, Alzheimer's disease model mice, and specific RAGE-deficient mice using the Cre-loxp system.
What problem does it help solve?
Cognitive impairment due to obesity and diabetes is an issue that needs to be resolved and is attracting attention. If this study reveals the involvement of RAGE in peripheral immune cells, as well as inflammation in the brain and cerebrovascular system, subclinical inflammation, and cognitive impairment, it is expected that this will lead to the resolution of the above issues.
Possibility of other applications and developments
―
Related Patents
―
Related papers
Researcher Information
full name | Hidenori Koyama |
---|---|
Affiliation | School of Medicine Department of Diabetes Endocrinology and Clinical Immunology |
Specialization | Research into the onset and prevention of cognitive impairment in lifestyle-related diseases and diabetes |
Collaborative Researcher | Akio Miyoshi |
Related links | Laboratory website |
What do you expect from collaboration with companies?
We are currently elucidating the function of RAGE in vascular endothelium and immune cells.
We hope to collaborate with companies in joint research that will lead to the diagnosis, prevention, and treatment of cognitive impairment.
Contact for this research
兵庫医科大学 大学事務部 研究推進課
E-mail: chizai@hyo-med.ac.jp
Tel: 0798-45-6488